Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation

Journal of Hepatology

Volumn 59, Issue 6, 2013, Pages 1299-1306

  Cao, Yanan ^a   Xue, Ying ^a   Xue, Lu ^a   Jiang, Xiuli ^a   Wang, Xiaolin ^a   Zhang, Zhijian ^a   Yang, Jian ^a   Lu, Jieli ^a   Zhang, Changxian ^b   Wang, Weiqing ^a   Ning, Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CENTRE LÉON BÉRARD   (France)

Author keywords

Aging; Histone deacetylation; Liver steatosis; Menin; SIRT1

Indexed keywords

CD36 ANTIGEN; CRE RECOMBINASE; FATTY ACID SYNTHASE; METHIONINE; SIRTUIN 1; TRIACYLGLYCEROL;

AGING; ANIMAL CELL; ARTICLE; BINDING SITE; BODY WEIGHT; CONTROLLED STUDY; DEACETYLATION; DISEASE CONTROL; DISEASE COURSE; FAT INTAKE; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; FATTY LIVER; GENE DELETION; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HISTONE ACETYLATION; HISTONE METHYLATION; INSULIN TOLERANCE TEST; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER CELL; LIVER WEIGHT; LOXP SITE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

AGING; HFD; HIGH-FAT DIET; HISTONE DEACETYLATION; INSULIN TOLERANCE TESTS; INTRA-PERITONEAL GLUCOSE TOLERANCE TESTS; IPGTT; ITT; LIVER STEATOSIS; LIVER-SPECIFIC MEN1 KNOCKOUT MICE; LMKO; MEN1; MENIN; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NAFLD; NON-ALCOHOLIC FATTY LIVER DISEASE; SCD-1; SIRT1; STEAROYL COA DESATURASE-1; TC; TG; TOTAL CHOLESTEROL; TRIGLYCERIDE;

ACETYLATION; AGING; ANIMALS; ANTIGENS, CD36; DIET, HIGH-FAT; FATTY LIVER; GLUCOSE; HISTONES; LIVER; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS; SIRTUIN 1;

EID: 84887993574     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.07.011     Document Type: Article

References (50)

1. P. Angulo Non-alcoholic fatty liver disease N Engl J Med 346 2002 1221 1231
2. L. Gan, S. Chitturi, and G.C. Farrell Mechanisms and implications of age-related changes in the liver: non-alcoholic Fatty liver disease in the elderly Curr Gerontol Geriatr Res 2011 2011 831536
3. J.C. Cohen, J.D. Horton, and H.H. Hobbs Human fatty liver disease: old questions and new insights Science 332 2011 1519 1523
4. J. Jin, G.L. Wang, P. Iakova, X. Shi, S. Haefliger, and M. Finegold Epigenetic changes play critical role in age-associated dysfunctions of the liver Aging Cell 9 2010 895 910
5. J. Jin, P. Iakova, Y. Jiang, E.E. Medrano, and N.A. Timchenko The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation Hepatology 54 2011 989 998
6. O. Bezy, T.T. Tran, J. Pihlajamäki, R. Suzuki, B. Emanuelli, and J. Winnay PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans J Clin Invest 121 2011 2504 2517
7. S. Imai, C.M. Armstrong, M. Kaeberlein, and L. Guarente Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase Nature 403 2000 795 800
8. L. Bordone, and L. Guarente Calorie restriction, SIRT1 and metabolism: understanding longevity Nat Rev Mol Cell Biol 6 2005 298 305
9. J.T. Rodgers, C. Lerin, W. Haas, S.P. Gygi, B.M. Spiegelman, and P. Puigserver Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 Nature 434 2005 113 118
10. C. Escande, C.C. Chini, V. Nin, K.M. Dykhouse, C.M. Novak, and J. Levine Deleted in breast cancer-1 regulates SIRT1 activity and contributes to high-fat diet-induced liver steatosis in mice J Clin Invest 120 2010 545 558
11. D. Chen, J. Bruno, E. Easlon, S.J. Lin, H.L. Cheng, and F.W. Alt Tissue-specific regulation of SIRT1 by calorie restriction Genes Dev 22 2008 1753 1757
12. A.S. Banks, N. Kon, C. Knight, M. Matsumoto, R. Gutiérrez- Juárez, and L. Rossetti SirT1 gain of function increases energy efficiency and prevents diabetes in mice Cell Metab 8 2008 333 341
13. P.T. Pfluger, D. Herranz, S. Velasco-Miguel, M. Serrano, and M.H. Tschöp Sirt1 protects against high-fat diet-induced metabolic damage Proc Natl Acad Sci U S A 105 2008 9793 9798
14. A. Purushotham, T.T. Schug, Q. Xu, S. Surapureddi, X. Guo, and X. Li Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation Cell Metab 9 2009 327 338
15. M. Lagouge, C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, and F. Daussin Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 127 2006 1109 1122
16. S. Valentini, F. Cabreiro, D. Ackerman, M.M. Alam, M.B. Kunze, and C.W. Kay Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer Nat Commun 1 2010 1 8
17. P. Bertolino, W.M. Tong, P.L. Herrera, H. Casse, C.X. Zhang, and Z.Q. Wang Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice Cancer Res 63 2003 4836 4841
18. A. Yokoyama, T.C. Somervaille, K.S. Smith, O. Rozenblatt-Rosen, M. Meyerson, and M.L. Cleary The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis Cell 123 2005 207 218
19. H. Kaji Menin and bone metabolism J Bone Miner Metab 30 2012 381 387
20. C. Heppner, K.Y. Bilimoria, S.K. Agarwal, M. Kester, L.J. Whitty, and S.C. Guru The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation Oncogene 20 2001 4917 4925
21. K.M. Dreijerink, R.A. Varier, O. van Beekum, E.H. Jeninga, J.W. Höppener, and C.J. Lips The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation Mol Cell Biol 29 2009 5060 5069
22. Y. Cao, R. Liu, X. Jiang, J. Lu, J. Jiang, and C. Zhang Nuclear-cytoplasmic shuttling of menin regulates nuclear translocation of β-catenin Mol Cell Biol 29 2009 5477 5487
23. H. Kim, J.E. Lee, E.J. Cho, J.O. Liu, and H.D. Youn Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex Cancer Res 63 2003 6135 6139
24. T.A. Milne, C.M. Hughes, R. Lloyd, Z. Yang, O. Rozenblatt-Rosen, and Y. Dou Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors Proc Natl Acad Sci U S A 102 2005 749 754
25. H. Zhang, W. Li, Q. Wang, X. Wang, F. Li, and C. Zhang Glucose-mediated repression of menin promotes pancreatic β-cell proliferation Endocrinology 153 2012 602 611
26. L. Wuescher, K. Angevine, T. Hinds, S. Ramakrishnan, S.M. Najjar, and E.J. Mensah-Osman Insulin regulates menin expression, cytoplasmic localization, and interaction with FOXO1 Am J Physiol Endocrinol Metab 301 2011 E474 E483
27. P. Cheng, S.S. Yang, X.G. Hu, X.Y. Zhou, Y.J. Zhang, and G. Jin Menin prevents liver steatosis through co-activation of peroxisome proliferator-activated receptor alpha FEBS Lett 585 2011 3403 3408
28. A.M. Wägner, J.M. Martín-Campos, C. Mayoral, A. de Leiva, and F. Blanco-Vaca Patients with MEN-1 are more insulin-resistant than their non-affected relatives Eur J Intern Med 16 2005 507 509
29. P.G. Dean, J.A. van Heerden, D.R. Farley, G.B. Thompson, C.S. Grant, and W.S. Harmsen Are patients with multiple endocrine neoplasia type I prone to premature death? World J Surg 24 2000 1437 1441
30. R.W. McCallum, V. Parameswaran, and J.R. Burgess Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose Clin Endocrinol (Oxf) 65 2006 163 168
31. P.C. Scacheri, J.S. Crabtree, A.L. Kennedy, G.P. Swain, J.M. Ward, and S.J. Marx Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1 Mamm Genome 15 2004 872 877
32. J. Zhou, M. Febbraio, T. Wada, Y. Zhai, R. Kuruba, and J. He Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis Gastroenterology 134 2008 556 567
33. J.H. Choi, K.H. Nam, J. Kim, M.W. Baek, J.E. Park, and H.Y. Park Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice Arterioscler Thromb Vasc Biol 25 2005 2404 2409
34. +-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control Cell 134 2008 329 340
35. F. Xu, Z. Gao, J. Zhang, C.A. Rivera, J. Yin, and J. Weng Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1± mice: a role of lipid mobilization and inflammation Endocrinology 151 2010 2504 2514
36. V.T. Samuel, K.F. Petersen, and G.I. Shulman Lipid-induced insulin resistance: unravelling the mechanism Lancet 375 2010 2267 2677
37. M. Monetti, M.C. Levin, M.J. Watt, M.P. Sajan, S. Marmor, and B.K. Hubbard Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver Cell Metab 6 2007 69 78
38. F. Benhamed, P.D. Denechaud, M. Lemoine, C. Robichon, M. Moldes, and J. Bertrand-Michel The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans J Clin Invest 122 2012 2176 2194
39. J.A. Ibdah, P. Perlegas, Y. Zhao, J. Angdisen, H. Borgerink, and M.K. Shadoan Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance Gastroenterology 128 2005 1381 1390
40. H.Y. Lin, I.C. Yu, R.S. Wang, Y.T. Chen, N.C. Liu, and S. Altuwaijri Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor Hepatology 47 2008 1924 1935
41. P.M. Ghosh, Z.J. Shu, B. Zhu, Z. Lu, Y. Ikeno, and J.L. Barnes Role of β-adrenergic receptors in regulation of hepatic fat accumulation during aging J Endocrinol 213 2012 251 261
42. Y. Liu, D. Zhou, F. Zhang, Y. Tu, Y. Xia, and H. Wang Liver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosis J Lipid Res 53 2012 358 367
43. L. Fontana, E. Zhao, M. Amir, H. Dong, K. Tanaka, and M.J. Czaja Aging promotes the development of diet-induced murine steatohepatitis but not steatosis Hepatology 57 2013 995 1004
44. T.T. Schug, and X. Li Sirtuin 1 in lipid metabolism and obesity Ann Med 43 2011 198 211
45. C. Kenyon The genetics of ageing Nature 464 2010 504 512
46. X. Xu, L.K. Hueckstaedt, and J. Ren Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: role of autophagy J Hepatol 59 2013 308 317
47. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to non-alcoholic fatty liver disease Nat Genet 40 2008 1461 1465
48. J.Z. Li, Y. Huang, R. Karaman, P.T. Ivanova, H.A. Brown, and T. Roddy Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis J Clin Invest 122 2012 4130 4144
49. L. Wuescher, K. Angevine, P.R. Patel, and E. Mensah-Osman Menin liver-specific hemizygous mice challenged with high fat diet show increased weight gain and markers of metabolic impairment Nutr Diabetes 2 2012 e34
50. P.J. Zindy, A. L'Helgoualc'h, D. Bonnier, A. Le Béchec, K. Bourd-Boitin, and C.X. Zhang Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesis Hepatology 44 2006 1296 1307